|4Sep 26, 4:08 PM ET

Kelly Leanne 4

4 · GRI BIO, Inc. · Filed Sep 26, 2023

Insider Transaction Report

Form 4
Period: 2023-09-22
Kelly Leanne
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-09-22$1.52/sh+83,333$126,66683,333 total
    Exercise: $1.52Exp: 2033-09-22Common Stock (83,333 underlying)
Footnotes (1)
  • [F1]Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 36 equal monthly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant.

Documents

1 file
  • 4
    wk-form4_1695758927.xmlPrimary

    FORM 4